An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer

An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer

Abstract Background The neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) are associated with poor prognoses in patients with gastric cancer; however, few studies have focused on the dynamic changes in these ratios during the treatment of patients with gastric cancer. H...

Full description

Bibliographic Details
Main Authors: Mikito Mori, Kiyohiko Shuto, Chihiro Kosugi, Kazuo Narushima, Hideki Hayashi, Hisahiro Matsubara, Keiji Koda
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Gastric cancer
Neutrophil-to-lymphocyte ratio
Platelet-to-lymphocyte ratio
Adjuvant chemotherapy
Overall survival
Relapse-free survival
Online Access:http://link.springer.com/article/10.1186/s12885-018-5171-2

Similar Items

Similar Items